高频喷射通气与自主呼吸用于肺肿瘤经皮冷冻消融:不良事件与操作效率比较
这项回顾性研究纳入2017年1月1日至2023年5月31日接受CT引导经皮肺肿瘤冷冻消融的连续成人患者,比较全身麻醉下高频喷射通气(HFJV)与中度镇静下自主呼吸(SR)的主要不良事件和操作效率。HFJV组与SR组主要不良事件率分别为8%和5%(p=0.46),无系统性空气栓塞发生;HFJV组房间时间中位数154分钟,长于SR组的127分钟(p<0.001)。HFJV似乎与SR同样安全,但房间时间更长。
要点
- HFJV组与SR组主要不良事件率分别为8%和5%,差异无统计学意义(p=0.46),无系统性空气栓塞发生。
- HFJV组房间时间中位数154分钟,长于SR组的127分钟(p<0.001)。
- HFJV更多用于单次治疗多个肿瘤(43% vs 19%)和非外周位置肿瘤(48% vs 24%)。
核心结论
- HFJV似乎与SR同样安全,但房间时间更长;HFJV可用于复杂病例,且不显著影响住院时间≥2天、操作时间或辐射暴露。
研究设计与样本
- 回顾性研究,纳入2017年1月1日至2023年5月31日接受CT引导经皮肺肿瘤冷冻消融的连续成人患者139例(85例女性、54例男性;中位年龄68岁),共310个肺肿瘤(82%为转移瘤),208次冷冻消融(HFJV组n=129,SR组n=79)。
诊断标准与关键数值
- 主要不良事件定义为术后30天内Common Terminology Criteria for Adverse Events grade ≥ 3。
- HFJV组主要不良事件率为8%,SR组为5%(p=0.46)。
- HFJV组房间时间中位数154分钟,SR组为127分钟(p<0.001)。
- HFJV组麻醉时间中位数136分钟。
- 住院时间≥2天者占17%,HFJV与SR间差异无统计学意义(p=0.64),调整每次消融探针数、慢性阻塞性肺疾病和操作者经验后仍无显著差异(p=0.53)。
临床应用与阅片要点
- 经皮肺消融时通气方式的选择应基于患者特征、预期操作需求以及操作者偏好。
- HFJV组与SR组在操作时间、CT引导采集时间、CT引导辐射剂量、总辐射剂量、气胸及需要胸腔置管的气胸频率上均无显著差异(均p>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. High-frequency jet ventilation (HFJV) facilitates accurate probe placement in percutaneous ablation of lung tumors but may increase risk for adverse events, including systemic air embolism. OBJECTIVE. The purpose of this study was to compare major adverse events and procedural efficiency of percutaneous lung ablation with HFJV under general anesthesia to spontaneous respiration (SR) under moderate sedation. METHODS. This retrospective study included consecutive adults who underwent CT-guided percutaneous cryoablation of one or more lung tumors with HFJV or SR between January 1, 2017, and May 31, 2023. We compared major adverse events (Common Terminology Criteria for Adverse Events grade ≥ 3) within 30 days postprocedure and hospital length of stay (HLOS) of 2 days or more using logistic regression analysis. We compared procedure time, room time, CT guidance acquisition time, CT guidance radiation dose, total radiation dose, and pneumothorax using generalized estimating equations. RESULTS. Overall, 139 patients (85 women, 54 men; median age, 68 years) with 310 lung tumors (82% metastases) underwent 208 cryoablations (HFJV, n = 129; SR, n = 79). HFJV showed greater rates than SR for the treatment of multiple tumors per session (43% vs 19%, respectively; p = .02) and tumors in a nonperipheral location (48% vs 24%, p < .001). Major adverse event rate was 8% for HFJV and 5% for SR (p = .46). No systemic air embolism occurred. HLOS was 2 days or more in 17% of sessions and did not differ significantly between HFJV and SR (p = .64), including after adjusting for probe number per session, chronic obstructive pulmonary disease, and operator experience (p = .53). Ventilation modalities showed no significant difference in procedure time, CT guidance acquisition time, CT guidance radiation dose, or total radiation dose (all p > .05). Room time was longer for HFJV than SR (median, 154 vs 127 minutes, p < .001). For HFJV, the median anesthesia time was 136 minutes. Ventilation modalities did not differ in the frequencies of pneumothorax or pneumothorax requiring chest tube placement (both p > .05). CONCLUSION. HFJV appears to be as safe as SR but had longer room times. HFJV can be used in complex cases without significantly impacting HLOS of 2 days or more, procedure time, or radiation exposure. CLINICAL IMPACT. Selection of the ventilation modality during percutaneous lung ablation should be based on patient characteristics and anticipated procedural requirements as well as operator preference.
引用
- Graur A, Mercaldo ND, Simon J, et al. High-Frequency Jet Ventilation Versus Spontaneous Respiration for Percutaneous Cryoablation of Lung Tumors: Comparison of Adverse Events and Procedural Efficiency. AJR Am J Roentgenol. 2024. PMID: 38264999. doi:10.2214/AJR.23.30557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。